
VP of Engineering & Informatics @Resilience. Creating innovative solutions and crafting solutions to improve human health. Tweets are my own.
San Diego, CA
Joined February 2017
- Tweets116
- Following112
- Followers105
- Likes618
Dwight Baker retweeted
Today is #WorldCancerDay. As a technology-focused biomanufacturing company, we are proud to support multiple partners within the oncology space. We remain committed to working alongside our partners to provide lifesaving treatments for cancer patients.
Dwight Baker retweeted
NEWS: We’re excited to share that we have entered into a collaboration with @MayoClinic to manufacture and deliver novel biotherapeutics for rare and complex conditions. Learn more here: hubs.ly/Q01k0Wyr0
#biologics #biomanufacturing
Dwight Baker retweeted
We are excited to collaborate with you on this important issue!
This Post is from an account that no longer exists. Learn more
Dwight Baker retweeted
We are excited to announce the Department of Defense has awarded us a contract to develop a treatment for botulinum neurotoxins. Read more about this news here: https://nitter.cf/t.co/ir8kglFtJu
#USDeptofDefense #Resilience #Alachua and #Botulinum
Dwight Baker retweeted
600 organizations, 55 elected officials and 120,000 California residents agree: We need to reverse the disastrous CPUC decision and protect rooftop solar. Join us in calling on @GavinNewsom to #SaveSolar. environmentcalifornia.webact…
Dwight Baker retweeted
Resilience is a technology-focused biomanufacturing company aiming to revolutionize the way medicines are made. Read the latest news about our work in vaccines, biologics, nucleic acids and cell & gene therapies: https://nitter.cf/t.co/e7wYChKaDC
Dwight Baker retweeted
Resilience continues to build its unique technology base with acquisition of SwiftScale.
News: we acquired SwiftScale Biologics, a leader in cell-free protein synthesis, a biomanufacturing process that can produce drugs faster with greater scalability. This technology is a promising avenue to produce next-generation therapies -- read more: bwnews.pr/3IitT9k
Dwight Baker retweeted
News: we acquired SwiftScale Biologics, a leader in cell-free protein synthesis, a biomanufacturing process that can produce drugs faster with greater scalability. This technology is a promising avenue to produce next-generation therapies -- read more: bwnews.pr/3IitT9k
Dwight Baker retweeted
We are excited to announce our collaboration with ATP's Intergalactic Therapeutics today - Resilience will manufacture products for Intergalactic's first in human clinical trials, and help advance their novel cell-free manufacturing. More info here: prn.to/3DkvmZb
Moderna turns to @IncResilience to ramp up Covid vaccine manufacturing statnews.com/2021/09/08/mode… via @statnews @rsinghvi
Dwight Baker retweeted
We're excited to announce today a strategic alliance with @bluebirdbio to develop next-generation cell therapies: bwnews.pr/376EsLa
Dwight Baker retweeted
We’re committing US $60M in #sequencing capabilities to a global pathogen genomics initiative, in partnership with @GatesFoundation and others, to strengthen #publichealth systems in areas of need.
illumina.com/company/news-ce…
Illumina is on #TIME100Companies: an inaugural list of the world's most influential businesses. Unlocking the power of the genome to improve human health. ti.me/3aHPjNS
3













